OMNI BIO PHARMACEUTICAL
We are a biopharmaceutical company that was formed to explore new methods of use of AAT, also referred to as "plasma-derived AAT" (“p-AAT”). p-AAT is purified from human blood and is currently believed to be one of the body's most powerful anti-inflammatory proteins. p-AAT has a greater than 25-year safety record as an approved treatment for emphysema in AAT-deficient patients. Our initial strategy was based on licensing issued and pending "method- of-use" patents that cover new treatment... indications for AAT and commercializing these through royalty agreements with existing AAT manufacturers. Our initial targeted markets were infectious diseases, including biohazards, but in 2009 we changed our focus to certain auto-immune and inflammatory diseases, such as Type 1 diabetes (also known as juvenile diabetes).
OMNI BIO PHARMACEUTICAL
Industry:
Biopharma Biotechnology Finance Health Care Pharmaceutical
Founded:
2005-12-01
Address:
Greenwood Village, Colorado, United States
Country:
United States
Website Url:
http://www.omnibiopharma.com
Total Employee:
1+
Status:
Active
Contact:
(720) 488-4754
Email Addresses:
[email protected]
Total Funding:
10.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Font Awesome Domain Not Resolving Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.omnibiopharma.com
Unable to get host informations!!!
